View by Specialty
Log in or Sign up for Free to view tailored content for your specialty!
Hidradenitis Suppurativa News
SPONSORED CONTENT
February 06, 2023
1 min read
Save
Cosentyx sustains hidradenitis suppurativa improvement up to 1 year
In two phase 3 trials, patients with moderate to severe hidradenitis suppurativa taking Cosentyx continued to improve beyond the primary endpoint analysis and up to 52 weeks, Novartis announced in a press release.
Log in or Sign up for Free to view tailored content for your specialty!
Subscribe to Healio Minute emails
You're now subscribed to Healio Minute Emails
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
Subscribe to Healio Minute emails
You're now subscribed to Healio Minute Emails
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read